恶性症状群(下称NMS)是一组罕见的,且有可能致命的神经阻滞剂的特异反应。临床特点是:肌强直、发热、植物神经功能紊乱和不同程度的意识障碍。NMS1968年由法国精神病学家Delay命名。直到八十年代才引起各国学者的重视。本文据不全统计资料约有170例NMS患者,其中包括shalev等收集的英、法文 The Malignant Syndrome (NMS) is a group of rare and potentially lethal neuroprotective agents that respond specifically. Clinical features are: muscle rigidity, fever, autonomic dysfunction and varying degrees of disturbance of consciousness. NMS1968 by the French phlebotomy Delay named. It was not until the 1980s that scholars in various countries paid attention to it. This article according to incomplete statistics about 170 cases of NMS patients, including shalev and other collected English, French